Literature DB >> 32031802

Metabolomics Approach Expands the Classification of Propolis Samples from Midwest Brazil.

Alberto G Costa1, Nídia C Yoshida1, Walmir S Garcez1, Renata T Perdomo2, Maria de Fátima C Matos2, Fernanda R Garcez1.   

Abstract

Propolis samples collected from five areas in Mato Grosso do Sul state, Midwest Brazil, comprising portions of the Cerrado, Pantanal, and Atlantic Forest ecosystems, were investigated for metabolomic profiles and evaluated for antioxidant and antitumor potential. Chemical profiles were determined by HPLC-DAD-MS/MS data and evaluated using principal component analysis and hierarchical clustering analysis to discern chemical composition patterns. Based on phytogeographical origin and chemical composition, 20 potential markers were identified and five groups were distinguished: (I) Cerrado/Central, (II) Atlantic Forest/South, (III) Cerrado-Pantanal transition area/Northwest, (IV) Cerrado/North, and (V) Pantanal/West. Drawing on HPLC-DAD-MS/MS and NMR data, 47 compounds were successfully or tentatively identified, including prenylated phenylpropanoids, flavonoids, isoflavonoids, and di- and triterpenoids, among other constituents. Isoflavonoids, typically found in red propolis from Northeast Brazil, are being reported for the first time in a propolis sample from the Midwest. A new prenylated aromatic compound, (E)-3-[4-hydroxy-3-(2-hydroxy-3-methylbut-3-en-1-yl)-5-(3-methylbut-2-en-1-yl)phenyl]propenoic acid, was obtained. Samples in group II exhibited promising antitumor potential against prostate and breast carcinoma cells, as did samples in groups III and IV against the latter cell line. The sample in group I, despite containing the highest amount of total phenolic compounds and being the only sample to exhibit scavenging activity against DPPH, was not the most cytotoxic against the cell lines tested.

Entities:  

Year:  2020        PMID: 32031802     DOI: 10.1021/acs.jnatprod.9b00783

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  2 in total

1.  The Potential Use of Propolis as an Adjunctive Therapy in Breast Cancers.

Authors:  Dedy Hermansyah; Felix Zulhendri; Conrad O Perera; Naufal N Firsty; Kavita Chandrasekaran; Rizky Abdulah; Herry Herman; Ronny Lesmana
Journal:  Integr Cancer Ther       Date:  2022 Jan-Dec       Impact factor: 3.077

2.  Extraction, Antioxidant Capacity, 5-Lipoxygenase Inhibition, and Phytochemical Composition of Propolis from Eastern Canada.

Authors:  Mariama Sambou; Jacques Jean-François; Fanta J Ndongou Moutombi; Jérémie A Doiron; Mathieu P A Hébert; Andrew P Joy; Ngoc-Nu Mai-Thi; David A Barnett; Marc E Surette; Luc H Boudreau; Mohamed Touaibia
Journal:  Molecules       Date:  2020-05-21       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.